Recent HZNP Stock Price | HZNP Stock Predictions | |
$87.38 | ![]() +56.79% |
$137.00 |
Recent HZNP Analyst Ratings Breakdown, Making HZNP Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 10 | 10 | 10 | 9 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.05 | 1.05 | 1.05 | 1.05 |
For the HZNP stock predictions from the analysts covering Horizon Therapeutics Plc, we have collected all of the individual HZNP stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 11 different analysts covering HZNP (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since HZNP stock predictions may vary widely, another useful metric to consider is the median HZNP stock prediction, which represents the price at which half of the analysts
made HZNP stock predictions that were higher and half made HZNP stock predictions that were lower. This makes for a different take on the HZNP stock predictions out there, as compared to average or mean.
And that median across all the individual HZNP stock predictions was: $137.0 as of 2022-05-24.
The very highest of the HZNP stock predictions for one year price target was $155.0, while the very lowest of the HZNP stock predictions in the analyst group was
$121.0 (with a standard deviation of $8.378). Get the latest Zacks research report on HZNP — FREE
Find out: HZNP next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
KEP Stock Predictions
ADM Stock Predictions
HLNE Stock Predictions
MRSN Stock Predictions
LOPE Stock Predictions
INOV Stock Predictions
RGS Stock Predictions
CBNK Stock Predictions
LBAI Stock Predictions
![]()
![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() Strong Buy (3.79 out of 4) 64th percentile
(ranked higher than approx. 64% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |
![]() ![]() |